Market Overview:
The global preclinical in-vivo imaging market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth of this market can be attributed to the increasing demand for preclinical in-vivo imaging systems for research and development (R&D) and drug discovery applications. The other segment, which includes positron emission tomography/computed tomography (PET/CT), magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), and X-ray computed tomography (CT), is expected to grow at a higher CAGR than the optical imaging systems, micro-ultrasound systems, preclinical nuclear imaging systems, and other segments during the forecast period. The North America region is expected to hold the largest share of the global preclinical in-vivo Imaging market in 2018. This region is also projected to grow at a higher CAGR than other regions during the forecast period. The growth of this regional segment can be attributed to factors such as rising demand for better healthcare infrastructure, increasing R&D spending by pharmaceutical companies, growing number of CROs & contract research organizations present in this region, and rising prevalence of chronic diseases.
Product Definition:
Preclinical in vivo imaging is the process of creating images of organs or tissues in a living organism. This technology can be used to track the progress of a disease or test the effectiveness of a new drug. In addition, preclinical in vivo imaging can help scientists better understand how biological systems work.
Optical Imaging Systems:
Optical imaging systems are used for the noninvasive study of biological processes at a molecular level. These devices are gaining popularity in Preclinical In-vivo Imaging market due to their ability to provide high resolution images, which is not possible with other modalities.
Increasing demand for early disease diagnosis.
Micro-Ultrasound Systems:
Micro-ultrasound systems are used for noninvasive real-time visualization of target tissues and organs in live animals. These devices can be used for preclinical research to study the effect of potential drug candidates on target organs/tissues. Micro-Ultrasound Systems (MUS) is a noninvasive technique that produces high quality digital images of targeted areas, which helps researchers to understand the mechanism better during animal testing.
Application Insights:
Based on application, the global preclinical in-vivo imaging market is segmented into research and development, drug discovery, and others. Research and development held the largest share of the overall market in 2017 owing to increasing R&D activities for developing new drugs. Moreover, a large number of pharmaceutical companies are investing significantly in order to enhance their product pipeline for future commercialization. This has led to an increase in demand for advanced imaging systems that can be used efficiently during preclinical trials.
Drug discovery is anticipated to grow at a lucrative rate over the forecast period due largely to extensive R&D initiatives undertaken by various companies with an aim towards discovering novel targets/ biomarkers associated with diseases & disorders of high clinical significance such as cancer & tumor progression & metastasis as well as treatment resistance. The other applications include usage during toxicology studies or when it comes comes down to determining cause related death or disease progression which requires detailed analysis including histopathological examination etc.
Regional Analysis:
North America dominated the global preclinical in-vivo imaging market with a revenue share of over 35% in 2017. This is due to the presence of major players such as GE Healthcare, Koninklijke Philips N.V., and Siemens Healthineers AG that are continuously investing in R&D activities for development of advanced technologies for preclinical imaging.
The Asia Pacific region is expected to grow at a lucrative rate during the forecast period owing to increase in healthcare expenditure along with growing awareness regarding benefits offered by these systems within emerging countries like China and India.
Growth Factors:
- Increasing demand for in-vivo imaging owing to its ability to provide high-resolution images of organs and tissues
- Rising prevalence of chronic diseases, which is expected to increase the demand for preclinical in vivo imaging
- Technological advancements that are resulting in the development of new and more sophisticated imaging systems
- Growing number of research studies that are using preclinical in vivo imaging as a tool for studying various diseases
- Increasing use of preclinical in vivo imaging by pharmaceutical and biotechnology companies for drug discovery and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Preclinical In-vivo Imaging Market Research Report
By Type
Optical Imaging Systems, Micro-Ultrasound Systems, Preclinical Nuclear Imaging Systems, Other,
By Application
Research & Development, Drug Discovery,
By Companies
Bruker, Siemens, TriFoil Imaging, PerkinElmer, Fujifilm VisualSonics, MILabs, Mediso,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Preclinical In-vivo Imaging Market Report Segments:
The global Preclinical In-vivo Imaging market is segmented on the basis of:
Types
Optical Imaging Systems, Micro-Ultrasound Systems, Preclinical Nuclear Imaging Systems, Other,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research & Development, Drug Discovery,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bruker
- Siemens
- TriFoil Imaging
- PerkinElmer
- Fujifilm VisualSonics
- MILabs
- Mediso
Highlights of The Preclinical In-vivo Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Optical Imaging Systems
- Micro-Ultrasound Systems
- Preclinical Nuclear Imaging Systems
- Other
- By Application:
- Research & Development
- Drug Discovery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Preclinical In-vivo Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Preclinical in-vivo imaging is the use of imaging techniques to study the effects of drugs or other treatments on living organisms. This type of research can help scientists better understand how a particular treatment will work in humans, and can also help them identify potential side effects.
Some of the major companies in the preclinical in-vivo imaging market are Bruker, Siemens, TriFoil Imaging, PerkinElmer, Fujifilm VisualSonics, MILabs, Mediso.
The preclinical in-vivo imaging market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Preclinical In-vivo Imaging Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Preclinical In-vivo Imaging Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Preclinical In-vivo Imaging Market - Supply Chain
4.5. Global Preclinical In-vivo Imaging Market Forecast
4.5.1. Preclinical In-vivo Imaging Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Preclinical In-vivo Imaging Market Size (000 Units) and Y-o-Y Growth
4.5.3. Preclinical In-vivo Imaging Market Absolute $ Opportunity
5. Global Preclinical In-vivo Imaging Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Preclinical In-vivo Imaging Market Size and Volume Forecast by Type
5.3.1. Optical Imaging Systems
5.3.2. Micro-Ultrasound Systems
5.3.3. Preclinical Nuclear Imaging Systems
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Preclinical In-vivo Imaging Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Preclinical In-vivo Imaging Market Size and Volume Forecast by Application
6.3.1. Research & Development
6.3.2. Drug Discovery
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Preclinical In-vivo Imaging Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Preclinical In-vivo Imaging Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Preclinical In-vivo Imaging Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Preclinical In-vivo Imaging Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Preclinical In-vivo Imaging Demand Share Forecast, 2019-2026
9. North America Preclinical In-vivo Imaging Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Preclinical In-vivo Imaging Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Preclinical In-vivo Imaging Market Size and Volume Forecast by Application
9.4.1. Research & Development
9.4.2. Drug Discovery
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Preclinical In-vivo Imaging Market Size and Volume Forecast by Type
9.7.1. Optical Imaging Systems
9.7.2. Micro-Ultrasound Systems
9.7.3. Preclinical Nuclear Imaging Systems
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Preclinical In-vivo Imaging Demand Share Forecast, 2019-2026
10. Latin America Preclinical In-vivo Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Preclinical In-vivo Imaging Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Preclinical In-vivo Imaging Market Size and Volume Forecast by Application
10.4.1. Research & Development
10.4.2. Drug Discovery
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Preclinical In-vivo Imaging Market Size and Volume Forecast by Type
10.7.1. Optical Imaging Systems
10.7.2. Micro-Ultrasound Systems
10.7.3. Preclinical Nuclear Imaging Systems
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Preclinical In-vivo Imaging Demand Share Forecast, 2019-2026
11. Europe Preclinical In-vivo Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Preclinical In-vivo Imaging Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Preclinical In-vivo Imaging Market Size and Volume Forecast by Application
11.4.1. Research & Development
11.4.2. Drug Discovery
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Preclinical In-vivo Imaging Market Size and Volume Forecast by Type
11.7.1. Optical Imaging Systems
11.7.2. Micro-Ultrasound Systems
11.7.3. Preclinical Nuclear Imaging Systems
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Preclinical In-vivo Imaging Demand Share, 2019-2026
12. Asia Pacific Preclinical In-vivo Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Preclinical In-vivo Imaging Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Preclinical In-vivo Imaging Market Size and Volume Forecast by Application
12.4.1. Research & Development
12.4.2. Drug Discovery
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Preclinical In-vivo Imaging Market Size and Volume Forecast by Type
12.7.1. Optical Imaging Systems
12.7.2. Micro-Ultrasound Systems
12.7.3. Preclinical Nuclear Imaging Systems
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Preclinical In-vivo Imaging Demand Share, 2019-2026
13. Middle East & Africa Preclinical In-vivo Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Preclinical In-vivo Imaging Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Preclinical In-vivo Imaging Market Size and Volume Forecast by Application
13.4.1. Research & Development
13.4.2. Drug Discovery
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Preclinical In-vivo Imaging Market Size and Volume Forecast by Type
13.7.1. Optical Imaging Systems
13.7.2. Micro-Ultrasound Systems
13.7.3. Preclinical Nuclear Imaging Systems
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Preclinical In-vivo Imaging Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Preclinical In-vivo Imaging Market: Market Share Analysis
14.2. Preclinical In-vivo Imaging Distributors and Customers
14.3. Preclinical In-vivo Imaging Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bruker
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Siemens
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. TriFoil Imaging
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PerkinElmer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Fujifilm VisualSonics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MILabs
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mediso
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook